Skip to main content

Animations

MJFF Publications

7211 - 7220 of 8715 Results
Title
Year
  • Year
  • 2014
  • 2018
  • 2021
  • 2023
  • 2017
  • 2020
  • 2023
  • 2023
  • 2010
  • 2019
  • Summary Details
    OPEN
    Title: Independent Spanish Validation of the Unified Dyskinesia Rating Scale
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12065
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Myosin VI-Dependent Actin Cages Encapsulate Parkin-Positive Damaged Mitochondria
    Journal Name: Developmental Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.devcel.2018.01.007
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variants
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/hmg/ddab294
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01563-4
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00533-w
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nlad025
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009
    Citation Count: 199
  • Summary Details
    RESTRICTED
    Title: A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.035
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.